Harnessing preexisting influenza virus-specific immunity increases antibody responses against SARS-CoV-2.
J Virol
; 98(2): e0157123, 2024 Feb 20.
Article
in En
| MEDLINE
| ID: mdl-38206036
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Influenza Vaccines
/
COVID-19 Vaccines
Limits:
Animals
/
Humans
Language:
En
Journal:
J Virol
Year:
2024
Document type:
Article
Affiliation country:
Estados Unidos
Country of publication:
Estados Unidos